Best TWAS P=2.94e-10 · Best GWAS P=7.18e-12 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Brain Cerebellar Hemisphere | FAM86B3P | 0.28 | 0.27 | lasso | 8 | 0.28 | 5.4e-08 | -6.5 | 6.0 | 1.7e-09 | -0.83 | 0.06 | 0.93 | FALSE |
2 | GTEx | Brain Cerebellum | FAM86B3P | 0.19 | 0.14 | lasso | 5 | 0.16 | 1.8e-05 | -5.4 | 5.7 | 9.8e-09 | -0.85 | 0.07 | 0.92 | FALSE |
3 | GTEx | Brain Cortex | FAM86B3P | 0.14 | 0.05 | enet | 9 | 0.07 | 5.1e-03 | -5.5 | 5.3 | 8.9e-08 | -0.80 | 0.04 | 0.84 | FALSE |
4 | GTEx | Brain Frontal Cortex BA9 | FAM86B3P | 0.16 | 0.13 | enet | 27 | 0.10 | 1.1e-03 | -5.6 | 5.4 | 8.0e-08 | -0.72 | 0.08 | 0.81 | FALSE |
5 | GTEx | Cells Transformed fibroblasts | FAM86B3P | 0.23 | 0.33 | lasso | 11 | 0.38 | 8.4e-30 | -4.9 | -5.7 | 1.2e-08 | 0.82 | 0.65 | 0.35 | FALSE |
6 | GTEx | Colon Transverse | FAM86B3P | 0.13 | 0.04 | lasso | 8 | 0.04 | 4.4e-03 | -5.4 | -5.3 | 1.2e-07 | 0.78 | 0.12 | 0.58 | FALSE |
7 | GTEx | Esophagus Mucosa | FAM86B3P | 0.22 | 0.17 | lasso | 8 | 0.19 | 1.7e-12 | -4.9 | -5.8 | 5.8e-09 | 0.80 | 0.67 | 0.33 | FALSE |
8 | GTEx | Testis | FAM86B3P | 0.15 | 0.14 | lasso | 7 | 0.13 | 2.2e-06 | -5.5 | 5.6 | 2.4e-08 | -0.78 | 0.17 | 0.83 | FALSE |
9 | GTEx | Thyroid | SGK223 | 0.19 | 0.35 | enet | 16 | 0.36 | 1.1e-28 | -6.8 | 6.3 | 2.9e-10 | -0.95 | 0.00 | 1.00 | TRUE |
10 | ROSMAP | Brain Pre-frontal Cortex | FAM86B3P | 0.19 | 0.27 | bslmm | 331 | 0.27 | 5.6e-35 | -5.5 | 5.2 | 1.6e-07 | -0.65 | 0.87 | 0.13 | FALSE |
11 | ROSMAP | Brain Pre-frontal Cortex | FAM85B | 0.16 | 0.23 | enet | 18 | 0.22 | 1.8e-28 | -4.9 | 5.3 | 1.2e-07 | -0.79 | 0.97 | 0.03 | FALSE |
12 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | FLJ10661 | 0.10 | 0.16 | lasso | 1 | 0.15 | 6.1e-13 | -5.4 | -5.4 | 5.4e-08 | 0.74 | 0.02 | 0.98 | FALSE |
13 | The Cancer Genome Atlas | Colon Adenocarcinoma | FLJ10661 | 0.15 | 0.26 | lasso | 4 | 0.23 | 3.0e-13 | -5.4 | -5.5 | 4.8e-08 | 0.76 | 0.02 | 0.98 | FALSE |
14 | The Cancer Genome Atlas | Esophageal Carcinoma | FLJ10661 | 0.20 | 0.23 | lasso | 2 | 0.23 | 5.6e-08 | -5.6 | -5.5 | 4.2e-08 | 0.74 | 0.01 | 0.99 | FALSE |
15 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | FLJ10661 | 0.07 | 0.14 | lasso | 3 | 0.14 | 3.7e-15 | -5.4 | -5.5 | 3.9e-08 | 0.75 | 0.02 | 0.98 | FALSE |
16 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | FLJ10661 | 0.07 | 0.02 | blup | 42 | 0.04 | 2.9e-03 | -4.8 | -5.8 | 6.8e-09 | 0.75 | 0.02 | 0.79 | FALSE |
17 | The Cancer Genome Atlas | Brain Lower Grade Glioma | FLJ10661 | 0.21 | 0.26 | lasso | 9 | 0.30 | 2.3e-34 | -4.9 | 5.3 | 1.2e-07 | -0.77 | 0.04 | 0.95 | FALSE |
18 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | FLJ10661 | 0.11 | 0.06 | enet | 5 | 0.07 | 2.3e-05 | -5.4 | -5.1 | 2.8e-07 | 0.70 | 0.01 | 0.95 | FALSE |
19 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | FLJ10661 | 0.25 | 0.18 | lasso | 4 | 0.16 | 4.2e-07 | -5.6 | 5.9 | 4.7e-09 | -0.76 | 0.00 | 0.99 | FALSE |
20 | The Cancer Genome Atlas | Soft Tissue Sarcoma | FLJ10661 | 0.12 | 0.00 | blup | 42 | 0.00 | 6.9e-01 | -5.4 | -6.0 | 1.7e-09 | 0.64 | 0.01 | 0.51 | FALSE |
21 | The Cancer Genome Atlas | Stomach Adenocarcinoma | FLJ10661 | 0.08 | 0.05 | blup | 42 | 0.07 | 9.3e-06 | -4.8 | -5.7 | 1.0e-08 | 0.75 | 0.02 | 0.98 | FALSE |
22 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | FLJ10661 | 0.24 | 0.36 | enet | 8 | 0.35 | 4.1e-13 | -5.4 | -5.5 | 3.7e-08 | 0.75 | 0.02 | 0.98 | FALSE |
23 | The Cancer Genome Atlas | Thyroid Carcinoma | SGK223 | 0.16 | 0.20 | enet | 14 | 0.22 | 6.1e-21 | 4.1 | 5.3 | 1.3e-07 | -0.77 | 0.82 | 0.17 | FALSE |